Status:
COMPLETED
Study Evaluating The Prevalence Of Undiagnosed Psoriatic Arthritis In Patients With Plaque Psoriasis
Lead Sponsor:
Pfizer
Conditions:
Arthritis, Psoriatic
Psoriasis
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to collect Australian data on the prevalence of undiagnosed psoriatic arthritis in patients with plaque psoriasis. In addition the study will assess disease severity and quality of lif...
Detailed Description
Consecutive psoriasis patients seen at each site will be invited to participate in the study
Eligibility Criteria
Inclusion
- Diagnosis of plaque psoriasis
- \>= 18 years of age
- Able to complete English-language questionnaires
Exclusion
- Participation in an interventional clinical trial in previous 3 months
- Known rheumatologist-confirmed psoriatic arthritis
Key Trial Info
Start Date :
May 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2012
Estimated Enrollment :
458 Patients enrolled
Trial Details
Trial ID
NCT00998829
Start Date
May 1 2010
End Date
May 1 2012
Last Update
November 29 2012
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Camperdown, New South Wales, Australia, 2050
2
Pfizer Investigational Site
Darlinghurst, New South Wales, Australia, 2010
3
Pfizer Investigational Site
St Leonards, New South Wales, Australia, 2065
4
Pfizer Investigational Site
Westmead, New South Wales, Australia, 2145